Immutep Limited (IMMP) États Financiers et Données Historiques

Immutep Limited (IMMP) — Prix $0.33 HealthcareBiotechnology — NASDAQ

Derniers résultats publiés:

États financiers détaillés de Immutep Limited (IMMP): compte de résultat, bilan et tableau de flux de trésorerie. Suivez l'évolution des marges, de la dette, de la liquidité et de la rentabilité d'une année sur l'autre avec jusqu'à 20 ans d'historique.

Résumé de l'Analyse

Immutep Limited a enregistré un chiffre d'affaires de $14.2M sur le dernier exercice, avec un CAGR sur 5 ans de 29.8%.

Marges des 12 derniers mois: marge brute 85.0%, marge opérationnelle -6.0%, marge nette -5.4%.

Au prix actuel de $0.33, IMMP affiche des résultats négatifs (PER non significatif) et un ROE de -126.06%. La capitalisation boursière s'établit à $48M.

Compte de Résultat (10 ans)

Année2017201820192020202120222023202420252026
Revenus$4.2M$2.6M$139782$7.5M$3.9M$170369$3.5M$3.8M$5.0M$14.2M
Coût des Ventes$1.7M$10.0M$16.6M$22.5M$17.2M$2.1M$2.1M$41.5M$61.4M$2.4M
Marge Brute$2.5M-$7.4M-$16.5M-$15.0M-$13.4M-$1.9M$1.4M-$37.7M-$56.4M$11.8M
R&D$7.5M$10.0M$16.6M$20.4M$17.2M$31.3M$28.8M$41.5M$61.4M$75.0M
Frais Généraux$4.3M$7.2M$6.1M$6.3M$6.3M$7.2M$14.1M$8.9M$8.6M$18.9M
Charges Opérationnelles$9.5M$14.8M$19.1M$22.6M$18.3M$32.5M$44.9M$50.4M$70.1M$93.9M
Résultat Opérationnel-$9.4M-$11.7M-$20.4M-$16.0M-$31.7M-$33.9M-$77.7M-$88.1M-$126.4M-$82.0M
EBITDA-$8.4M-$10.4M-$16.5M-$11.4M-$17.8M-$31.9M-$39.6M-$44.5M-$62.9M-$79.6M
Charges d'Intérêt000$10457$9825$92430$20401$305940$66411
Résultat Avant Impôts-$10.1M-$12.7M-$18.3M-$13.5M-$29.9M-$32.2M-$39.9M-$42.7M-$61.4M-$77.6M
Impôts-$737387$1676-$2.1M$37$33$340000
Résultat Net-$9.4M-$12.7M-$16.3M-$13.5M-$29.9M-$32.2M-$39.9M-$42.7M-$61.4M-$77.6M
BPA$-0.44$-0.48$-0.47$-0.33$-0.49$-0.37$-0.44$-0.36$-0.42$-0.53
BPA Dilué$-0.44$-0.48$-0.47$-0.33$-0.49$-0.37$-0.44$-0.36$-0.42$-0.53
Actions en Circulation (Diluées)$42.7M$42.7M$42.7M$40.7M$60.4M$86.2M$90.1M$120.1M$145.6M$147.2M

Compte de Résultat (Trimestriel)

Année2024-Q42025-Q22025-Q42026-Q2
Revenus$3.1M$1.9M$6.0M$10.6M
Marge Brute-$22.2M-$34.2M-$40.6M$9.5M
Résultat Opérationnel-$51.7M-$74.7M-$46.0M-$39.5M
EBITDA-$26.4M-$36.5M-$44.9M-$38.5M
Résultat Net-$22.4M-$39.1M-$44.9M-$34.9M
BPA$-0.15$-0.27$-0.30$-0.23
BPA Dilué$-0.15$-0.27$-0.30$-0.23

Bilan (10 ans)

Année2017201820192020202120222023202420252026
Trésorerie$12.2M$23.5M$16.6M$26.3M$60.1M$80.0M$123.4M$161.8M$67.4M$68.9M
Placements à Court Terme0000000$20.1M$62.3M0
Créances$2.2M$3.5M$5.2M$3.4M$6.1M$8.4M$8.0M$7.6M$7460$9.6M
Stocks$641998000-$5.7M00000
Actifs Courants$15.9M$28.6M$23.5M$31.2M$68.4M$90.8M$135.0M$191.4M$149.1M$80.6M
Immobilisations Corporelles$24202$26449$52950$250571$309704$308080$468513$679723$569481$1.1M
Goodwill$109962$109962$109962$109962$109962$109962$109962$109962$109962$109967
Actifs Incorporels$18.9M$18.2M$16.8M$15.1M$12.7M$10.4M$9.4M$8.1M$7.1M$1.4M
Actifs Totaux$35.0M$47.0M$40.5M$46.6M$82.0M$102.2M$147.4M$201.6M$157.0M$83.3M
Dettes Fournisseurs$1.1M$1.6M$2.6M$1.6M$1.8M$2.9M$5.4M$3.8M$5.5M$5.9M
Dette à Court Terme0000$208194000$1.1M$290165
Passifs Courants$2.6M$3.9M$5.3M$3.4M$5.3M$6.4M$9.8M$10.5M$12.8M$14.2M
Dette à Long Terme$5.8M$6.6M$7.6M$8.8M$2.5M$1.5M$835446$96076300
Passifs Totaux$8.4M$13.5M$16.2M$13.3M$8.8M$8.1M$11.0M$12.1M$13.3M$21.7M
Réserves-$231.8M-$244.6M-$262.2M-$275.7M-$274.6M-$302.3M-$339.9M-$382.6M-$444.1M-$520.8M
Capitaux Propres$26.5M$33.5M$24.4M$33.3M$73.3M$94.1M$136.5M$189.5M$143.6M$61.5M
Dette Totale$5.8M$6.6M$7.6M$9.1M$2.8M$1.7M$1.2M$1.6M$1.6M$1.0M
Dette Nette-$6.5M-$16.8M-$8.9M-$17.3M-$57.3M-$78.3M-$122.2M-$180.3M-$128.1M-$67.8M
Fonds de Roulement$13.3M$24.8M$18.2M$27.8M$63.1M$84.4M$125.2M$180.9M$136.3M$66.5M

Bilan (Trimestriel)

Année2024-Q42025-Q22025-Q42026-Q2
Trésorerie$73.9M$67.4M$72.7M$68.9M
Actifs Totaux$182.3M$157.0M$147.2M$83.3M
Passifs Totaux$9.9M$13.3M$48.3M$21.7M
Capitaux Propres$172.5M$143.6M$98.9M$61.5M
Dette Totale$1.7M$1.6M$1.2M$1.0M

Tableau de Flux (10 ans)

Année2017201820192020202120222023202420252026
Résultat Net-$9.4M-$12.7M-$18.3M-$13.5M-$29.9M-$32.2M-$39.9M-$42.7M-$61.4M-$77.6M
Amortissements$1.7M$1.8M$1.9M$2.1M$2.1M$2.1M$2.1M$2.3M$2.4M$2.4M
Stock-based Compensation$862227$2.3M$1.6M$1.7M$1.7M$1.5M$2.0M$1.8M$1.2M0
Variation du BFR-$2.2M-$252216-$345187$94163-$2.0M-$1.6M$764596$3.5M-$8.5M$16.2M
Cash Flow Opérationnel-$8.5M-$7.8M-$15.3M-$10.8M-$17.6M-$30.2M-$35.9M-$34.8M-$62.0M-$54.3M
CapEx-$6644-$11893-$41434-$19348-$15601-$22914-$47000-$932369-$45769-$90895
Acquisitions0000000000
Rachat d'Actions0000000000
Dividendes Payés0000000000
Free Cash Flow-$8.5M-$7.8M-$15.3M-$10.9M-$17.7M-$30.3M-$35.9M-$35.8M-$62.1M-$54.3M

Tableau de Flux (Trimestriel)

Année2024-Q42025-Q22025-Q42026-Q2
Cash Flow Opérationnel-$28.5M-$33.5M-$28.1M-$29.1M
CapEx-$11501-$34268-$90961-$6601
Free Cash Flow-$28.6M-$33.5M-$28.2M-$29.2M
Dividendes Payés0000
Stock-based Compensation0$1.2M00

Croissance et Marges (10 ans)

Année2017201820192020202120222023202420252026
Croissance Revenus (annuelle)-37.7%-94.7%+5255.8%-48.4%-95.6%+1957.7%+9.6%+31.3%+182.3%
Croissance Résultat Net (annuelle)-36.1%-27.7%+17.2%-122.0%-7.7%-23.9%-7.1%-43.8%-26.3%
Croissance BPA (annuelle)-9.1%+2.1%+29.8%-48.5%+24.5%-18.9%+18.2%-16.7%-26.2%
Variation Actions (annuelle)+0.0%+0.0%-4.6%+48.4%+42.7%+4.4%+33.4%+21.2%+1.1%
Croissance FCF (annuelle)+8.5%-96.8%+29.2%-62.6%-71.3%-18.8%+0.5%-73.7%+12.5%
Marge Brute59.7%-279.8%-11769.3%-200.2%-346.2%-1111.2%41.2%-981.4%-1117.6%83.0%
Marge Opérationnelle-221.5%-444.5%-14606.5%-214.0%-820.0%-19920.0%-2216.0%-2293.3%-2506.5%-576.2%
Marge EBITDA-199.1%-394.5%-11778.9%-152.0%-460.0%-18708.9%-1128.8%-1159.4%-1246.6%-559.2%
Marge Nette-221.9%-484.6%-11640.0%-179.9%-774.1%-18906.5%-1138.0%-1111.9%-1218.0%-544.8%
Marge FCF-201.7%-296.1%-10965.5%-145.0%-457.1%-17757.1%-1024.9%-930.6%-1231.1%-381.7%
Taux d'Imposition Effectif7.3%-0.0%11.3%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%

Données par Action (10 ans)

Année2017201820192020202120222023202420252026
FCF par Action$-0.20$-0.18$-0.36$-0.27$-0.29$-0.35$-0.40$-0.30$-0.43$-0.37
Dividende par Action$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Actions en Circulation (Basiques)$42.7M$42.7M$42.7M$40.7M$60.4M$86.2M$90.1M$120.0M$145.6M$147.2M

Quoi regarder en Biotech

La plupart des petites biotechs perdent de l'argent. Les analyser avec le P/E n'a aucun sens — regardez cash et pipeline.

Rentabilité

Rentabilité des capitaux propres-126.06%
Rentabilité du capital investi-118.22%
Rentabilité des actifs-93.15%
Marge brute84.97%
Marge opérationnelle-597.44%
Marge nette-544.79%

Santé financière

Dette / Capitaux propres0.02
Ratio de liquidité5.69
Piotroski F-Score2
Altman Z-Score10.76

Ratios Clés (10 ans)

Année2017201820192020202120222023202420252026
PER-21.15-22.40-17.54-15.75-10.42-7.86-7.15-8.48-5.90-1.13
P/B15.0413.6414.406.384.252.702.091.912.531.44
P/V94.55173.762511.6528.3780.701488.2381.3594.2471.926.23
Marge Brute59.7%-279.8%-11769.3%-200.2%-346.2%-1111.2%41.2%-981.4%-1117.6%83.0%
Marge Opérationnelle-221.5%-444.5%-14606.5%-214.0%-820.0%-19920.0%-2216.0%-2293.3%-2506.5%-576.2%
Marge Nette-221.9%-484.6%-11640.0%-179.9%-774.1%-18906.5%-1138.0%-1111.9%-1218.0%-544.8%

Entreprises liées: ACHV · ALLO · CABA · CADL · CAPR · EDIT · MREO

Explorer le secteur: Healthcare · Biotechnology

Plus de sections de IMMP: Vue d'ensemble · Valorisation · Statistiques · Estimations · Technique · Actionnariat · Actualités · Événements

Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions